AFP EMA: Benefits Outweigh VTE Risks With Hormone Drugs for Acne - Medscape Medscape London, United Kingdom — The European Medicines Agency (EMA) has issued a recommendation that the benefits of the hormonal acne treatment Diane 35 (cyproterone acetate/ethinylestradiol) and its generics outweigh the risks, provided that several ... EU watchdog backs Bayer acne drug for certain patients Reuters Diane-35's benefit as acne drug outweigh risks, Health Canada finds CBC.ca Diane-35 Anti-Acne Pill More Beneficial Than Risky TestCountry.com (blog) AFP - FiercePharma - Toronto Star all 24 news articles »
Visit site:
EMA: Benefits Outweigh VTE Risks With Hormone Drugs for Acne - Medscape -
Brak komentarzy:
Prześlij komentarz